UBS raised the firm's price target on Box to $29 from $28 and keeps a Neutral rating on the shares. Box reported accelerating revenue growth into low-teens levels, with strong billings momentum and improving outlook driven by AI-related product traction, suggesting more durable near-term growth and supporting an upward revision to topline estimates, while margins and free cash flow expectations remain largely unchanged and the valuation is viewed as attractive, the analyst tells investors in a research note.
